CFD Analysis of BED Textural Characteristics on TBR Behavior: Hydrodynamics and Scaling-up

In recent years, CFD has played an important role in the understanding and design of TBR’s. In this work, through CFD with Eulerian approach, a three-phase heterogeneous reactor model was developed, were the accuracy of Interfacial Momentum Exchange Model (IMEM) for the gas-solid interaction, the effect of a more detailed catalytic bed geometry description, and the pellet shape over TBR hydrodynamics of two fluid phases interacting with the solid phase was studied. Then, a second model was developed, where the validated hy- drodynamic model was coupled with mass transport for an HDS process of light gasoil. Additionally, in order to insight into the scaling up process of a TBRs, the proposed columns behaviors were compared against lit- erature columns using four different ways, and it was found that the best predictions were obtained when the models’ holdup were equaled to those evaluated in literature columns. Since in reliable literature deviations in pressure drop predictions of around 30% can be found, the model results show significant improvement against literature, achieving 5 times better accuracy in predicting pressure drops, and 50% improvement in holdup prediction; the coupled model reproduces the same conversion values compared with literature data, and predicts conversions with 95% accurac

Electrochemical Mineralization of Ibuprofen on BDD Electrodes in an Electrochemical Flow Reactor: Numerical Optimization Approach

Statistical analysis was applied to optimize the electrochemical mineralization of ibuprofen with two boron-doped diamond (BDD) electrodes in a continuous electrochemical flow reactor under recirculation batch mode. A central composite rotatable (CCR) experimental design was used to analyze the e ect of initial pH (2.95–13.04), current intensity (2.66–4.34 A), and volumetric flow rate (0.16–1.84 L/min) and further optimized by response surface methodology (RSM) to obtain the maximum mineralization e ciency and the minimum specific energy consumption. A 91.6% mineralization e ciency (EM) of ibuprofen with a specific energy consumption (EC) of 4.36 KW h/g TOC within 7 h of treatment was achieved using the optimized operating parameters (pH0 = 12.29, I = 3.26 A, and Q of 1 L/min). Experimental results of RSM were fitted via a third-degree polynomial regression equation having the performance index determination coe cients (R2) of 0.8658 and 0.8468 for the EM and EC, respectively. The reduced root-mean-square error (RMSE) was 0.1038 and 0.1918 for EM and EC, respectively. This indicates an e cient predictive performance to optimize the operating parameters of the electrochemical flow reactor with desirability of 0.9999993. Besides, it was concluded that the optimized conditions allow to achieve a high percentage of ibuprofen mineralization (91.6%) and a cost of 0.002 USD $/L. Therefore, the assessed process is e cient for wastewater remediation.CONACyT (791495 y 740588

Degradation of 4-Chlorophenol in a Batch Electrochemical Reactor Using BDD Electrodes

The influence of current density (j) (0.25, 0.30, 0.25 and 0.40 A/cm2), initial pH (2.6, 6.5 and 12), stirring speed (As) (400, 500 and 600 rpm), and initial concentration of 4-chlorophenol ([4-CP]0) (300, 500 and 700 mg/L) on degradation of persistent pollutant in a batch electrochemical cell without divisions is presented in this paper. The electrochemical cell was composed of two boron-doped diamond electrodes (BDD). The results of the study showed that best conditions for total degradation of 4-CP were: j of 0.40 A/cm , initial pH of 6.5, As of 500 rpm, and [4-CP]0 of 500 mg/L, after 150 min of reaction time. Removal of total organic carbon (TOC) was 83% at these conditions. The byproducts were identified by UHPLC. This allowed for the proposal of a degradation pathway of 4-CP at the best conditions. Furthermore, these results demonstrate that the electrochemical method employed in this study allows high percentages (96%) of degradation of 4-CP and that the process is applicable to wastewater treatment.CONACYT 26909

Biodiesel production by reactive flash: A numerical simulation

Reactive flash (RF) in biodiesel production has been studied in order to investigate steady-state multiplicities, singularities, and effect of biodiesel quality when the RF system approaches to bubble point. The RF was modeled by an index-2 system of differential algebraic equations, the vapor split () was computed by modified Rachford-Rice equation and modified Raoult’s law computed bubble point, and the continuation analysis was tracked on MATCONT. Results of this study show the existence of turning points, leading to a unique bubble point manifold, , which is a globally stable flashing operation. Also, the results of the simulation in MATLAB® of the dynamic behavior of the RF show that conversion of triglycerides reaches 97% for a residence time of 5.8 minutes and a methanol to triglyceride molar flow ratio of 5 : 1

Risk of COVID-19 after natural infection or vaccinationResearch in context

Background: While vaccines have established utility against COVID-19, phase 3 efficacy studies have generally not comprehensively evaluated protection provided by previous infection or hybrid immunity (previous infection plus vaccination). Individual patient data from US government-supported harmonized vaccine trials provide an unprecedented sample population to address this issue. We characterized the protective efficacy of previous SARS-CoV-2 infection and hybrid immunity against COVID-19 early in the pandemic over three-to six-month follow-up and compared with vaccine-associated protection. Methods: In this post-hoc cross-protocol analysis of the Moderna, AstraZeneca, Janssen, and Novavax COVID-19 vaccine clinical trials, we allocated participants into four groups based on previous-infection status at enrolment and treatment: no previous infection/placebo; previous infection/placebo; no previous infection/vaccine; and previous infection/vaccine. The main outcome was RT-PCR-confirmed COVID-19 >7–15 days (per original protocols) after final study injection. We calculated crude and adjusted efficacy measures. Findings: Previous infection/placebo participants had a 92% decreased risk of future COVID-19 compared to no previous infection/placebo participants (overall hazard ratio [HR] ratio: 0.08; 95% CI: 0.05–0.13). Among single-dose Janssen participants, hybrid immunity conferred greater protection than vaccine alone (HR: 0.03; 95% CI: 0.01–0.10). Too few infections were observed to draw statistical inferences comparing hybrid immunity to vaccine alone for other trials. Vaccination, previous infection, and hybrid immunity all provided near-complete protection against severe disease. Interpretation: Previous infection, any hybrid immunity, and two-dose vaccination all provided substantial protection against symptomatic and severe COVID-19 through the early Delta period. Thus, as a surrogate for natural infection, vaccination remains the safest approach to protection. Funding: National Institutes of Health

Risk of COVID-19 after natural infection or vaccinationResearch in context

Summary: Background: While vaccines have established utility against COVID-19, phase 3 efficacy studies have generally not comprehensively evaluated protection provided by previous infection or hybrid immunity (previous infection plus vaccination). Individual patient data from US government-supported harmonized vaccine trials provide an unprecedented sample population to address this issue. We characterized the protective efficacy of previous SARS-CoV-2 infection and hybrid immunity against COVID-19 early in the pandemic over three-to six-month follow-up and compared with vaccine-associated protection. Methods: In this post-hoc cross-protocol analysis of the Moderna, AstraZeneca, Janssen, and Novavax COVID-19 vaccine clinical trials, we allocated participants into four groups based on previous-infection status at enrolment and treatment: no previous infection/placebo; previous infection/placebo; no previous infection/vaccine; and previous infection/vaccine. The main outcome was RT-PCR-confirmed COVID-19 >7–15 days (per original protocols) after final study injection. We calculated crude and adjusted efficacy measures. Findings: Previous infection/placebo participants had a 92% decreased risk of future COVID-19 compared to no previous infection/placebo participants (overall hazard ratio [HR] ratio: 0.08; 95% CI: 0.05–0.13). Among single-dose Janssen participants, hybrid immunity conferred greater protection than vaccine alone (HR: 0.03; 95% CI: 0.01–0.10). Too few infections were observed to draw statistical inferences comparing hybrid immunity to vaccine alone for other trials. Vaccination, previous infection, and hybrid immunity all provided near-complete protection against severe disease. Interpretation: Previous infection, any hybrid immunity, and two-dose vaccination all provided substantial protection against symptomatic and severe COVID-19 through the early Delta period. Thus, as a surrogate for natural infection, vaccination remains the safest approach to protection. Funding: National Institutes of Health

Global economic burden of unmet surgical need for appendicitis

Background There is a substantial gap in provision of adequate surgical care in many low- and middle-income countries. This study aimed to identify the economic burden of unmet surgical need for the common condition of appendicitis. Methods Data on the incidence of appendicitis from 170 countries and two different approaches were used to estimate numbers of patients who do not receive surgery: as a fixed proportion of the total unmet surgical need per country (approach 1); and based on country income status (approach 2). Indirect costs with current levels of access and local quality, and those if quality were at the standards of high-income countries, were estimated. A human capital approach was applied, focusing on the economic burden resulting from premature death and absenteeism. Results Excess mortality was 4185 per 100 000 cases of appendicitis using approach 1 and 3448 per 100 000 using approach 2. The economic burden of continuing current levels of access and local quality was US $92 492 million using approach 1 and$73 141 million using approach 2. The economic burden of not providing surgical care to the standards of high-income countries was $95 004 million using approach 1 and$75 666 million using approach 2. The largest share of these costs resulted from premature death (97.7 per cent) and lack of access (97.0 per cent) in contrast to lack of quality. Conclusion For a comparatively non-complex emergency condition such as appendicitis, increasing access to care should be prioritized. Although improving quality of care should not be neglected, increasing provision of care at current standards could reduce societal costs substantially

Global economic burden of unmet surgical need for appendicitis

Background There is a substantial gap in provision of adequate surgical care in many low- and middle-income countries. This study aimed to identify the economic burden of unmet surgical need for the common condition of appendicitis. Methods Data on the incidence of appendicitis from 170 countries and two different approaches were used to estimate numbers of patients who do not receive surgery: as a fixed proportion of the total unmet surgical need per country (approach 1); and based on country income status (approach 2). Indirect costs with current levels of access and local quality, and those if quality were at the standards of high-income countries, were estimated. A human capital approach was applied, focusing on the economic burden resulting from premature death and absenteeism. Results Excess mortality was 4185 per 100 000 cases of appendicitis using approach 1 and 3448 per 100 000 using approach 2. The economic burden of continuing current levels of access and local quality was US $92 492 million using approach 1 and$73 141 million using approach 2. The economic burden of not providing surgical care to the standards of high-income countries was $95 004 million using approach 1 and$75 666 million using approach 2. The largest share of these costs resulted from premature death (97.7 per cent) and lack of access (97.0 per cent) in contrast to lack of quality. Conclusion For a comparatively non-complex emergency condition such as appendicitis, increasing access to care should be prioritized. Although improving quality of care should not be neglected, increasing provision of care at current standards could reduce societal costs substantially